BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35561186)

  • 1. EDGE COVID-19: a web platform to generate submission-ready genomes from SARS-CoV-2 sequencing efforts.
    Lo CC; Shakya M; Connor R; Davenport K; Flynn M; Gutiérrez AMY; Hu B; Li PE; Jackson EP; Xu Y; Chain PSG
    Bioinformatics; 2022 May; 38(10):2700-2704. PubMed ID: 35561186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INSaFLU-TELEVIR: an open web-based bioinformatics suite for viral metagenomic detection and routine genomic surveillance.
    Santos JD; Sobral D; Pinheiro M; Isidro J; Bogaardt C; Pinto M; Eusébio R; Santos A; Mamede R; Horton DL; Gomes JP; ; Borges V
    Genome Med; 2024 Apr; 16(1):61. PubMed ID: 38659008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. InterARTIC: an interactive web application for whole-genome nanopore sequencing analysis of SARS-CoV-2 and other viruses.
    Ferguson JM; Gamaarachchi H; Nguyen T; Gollon A; Tong S; Aquilina-Reid C; Bowen-James R; Deveson IW
    Bioinformatics; 2022 Feb; 38(5):1443-1446. PubMed ID: 34908106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic Workflows.
    Connor R; Shakya M; Yarmosh DA; Maier W; Martin R; Bradford R; Brister JR; Chain PSG; Copeland CA; di Iulio J; Hu B; Ebert P; Gunti J; Jin Y; Katz KS; Kochergin A; LaRosa T; Li J; Li PE; Lo CC; Rashid S; Maiorova ES; Xiao C; Zalunin V; Purcell L; Pruitt KD
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benchmark datasets for SARS-CoV-2 surveillance bioinformatics.
    Xiaoli L; Hagey JV; Park DJ; Gulvik CA; Young EL; Alikhan NF; Lawsin A; Hassell N; Knipe K; Oakeson KF; Retchless AC; Shakya M; Lo CC; Chain P; Page AJ; Metcalf BJ; Su M; Rowell J; Vidyaprakash E; Paden CR; Huang AD; Roellig D; Patel K; Winglee K; Weigand MR; Katz LS
    PeerJ; 2022; 10():e13821. PubMed ID: 36093336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2.
    Carbo EC; Mourik K; Boers SA; Munnink BO; Nieuwenhuijse D; Jonges M; Welkers MRA; Matamoros S; van Harinxma Thoe Slooten J; Kraakman MEM; Karelioti E; van der Meer D; Veldkamp KE; Kroes ACM; Sidorov I; de Vries JJC
    Eur J Clin Microbiol Infect Dis; 2023 Jun; 42(6):701-713. PubMed ID: 37017810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ViralFlow: A Versatile Automated Workflow for SARS-CoV-2 Genome Assembly, Lineage Assignment, Mutations and Intrahost Variant Detection.
    Dezordi FZ; Neto AMDS; Campos TL; Jeronimo PMC; Aksenen CF; Almeida SP; Wallau GL; On Behalf Of The Fiocruz Covid-Genomic Surveillance Network
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of SARS-CoV-2 sequencing using the ONT GridION and the Illumina MiSeq.
    Tshiabuila D; Giandhari J; Pillay S; Ramphal U; Ramphal Y; Maharaj A; Anyaneji UJ; Naidoo Y; Tegally H; San EJ; Wilkinson E; Lessells RJ; de Oliveira T
    BMC Genomics; 2022 Apr; 23(1):319. PubMed ID: 35459088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Mutation Profiling of SARS-CoV-2 Variants from Multiple Raw Illumina Sequencing Data with Cloud Workflow.
    Lim HG; Hsiao SH; Fann YC; Lee YG
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 historical global testing and genomic variability.
    Tannous H; Akiki S; E Boulos R; El Khoury Eid C; El Hasbani G; Khoueiry LM; El Khoury L; Tohme R; Moussa R; Khazen G
    BMC Infect Dis; 2022 Apr; 22(1):322. PubMed ID: 35365069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UnCoVar: a reproducible and scalable workflow for transparent and robust virus variant calling and lineage assignment using SARS-CoV-2 as an example.
    Thomas A; Battenfeld T; Kraiselburd I; Anastasiou O; Dittmer U; Dörr AK; Dörr A; Elsner C; Gosch J; Le-Trilling VTK; Magin S; Scholtysik R; Yilmaz P; Trilling M; Schöler L; Köster J; Meyer F
    BMC Genomics; 2024 Jun; 25(1):647. PubMed ID: 38943066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CovidPhy: A tool for phylogeographic analysis of SARS-CoV-2 variation.
    Bello X; Pardo-Seco J; Gómez-Carballa A; Weissensteiner H; Martinón-Torres F; Salas A
    Environ Res; 2022 Mar; 204(Pt A):111909. PubMed ID: 34419470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study.
    Liu B; Liu K; Zhang H; Zhang L; Bian Y; Huang L
    J Med Internet Res; 2020 Oct; 22(10):e22299. PubMed ID: 32931441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A public website for the automated assessment and validation of SARS-CoV-2 diagnostic PCR assays.
    Li PE; Myers Y Gutiérrez A; Davenport K; Flynn M; Hu B; Lo CC; Player Jackson E; Shakya M; Xu Y; Gans JD; Chain PSG
    Bioinformatics; 2021 May; 37(7):1024-1025. PubMed ID: 32777813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of EPISEQ SARS-CoV-2 and a Fully Integrated Application to Identify SARS-CoV-2 Variants from Several Next-Generation Sequencing Approaches.
    Mugnier N; Griffon A; Simon B; Rambaud M; Regue H; Bal A; Destras G; Tournoud M; Jaillard M; Betraoui A; Santiago E; Cheynet V; Vignola A; Ligeon V; Josset L; Brengel-Pesce K
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From SARS-CoV-2 to Global Preparedness: A Graphical Interface for Standardised High-Throughput Bioinformatics Analysis in Pandemic Scenarios and Surveillance of Drug Resistance.
    Cumlin T; Karlsson I; Haars J; Rosengren M; Lennerstrand J; Pimushyna M; Feuk L; Ladenvall C; Kaden R
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
    Goswami C; Sheldon M; Bixby C; Keddache M; Bogdanowicz A; Wang Y; Schultz J; McDevitt J; LaPorta J; Kwon E; Buyske S; Garbolino D; Biloholowski G; Pastuszak A; Storella M; Bhalla A; Charlier-Rodriguez F; Hager R; Grimwood R; Nahas SA
    BMC Infect Dis; 2022 Apr; 22(1):404. PubMed ID: 35468749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 HaploGraph: visualization of SARS-CoV-2 haplotype spread in Japan.
    Nakagawa S; Katayama T; Jin L; Wu J; Kryukov K; Oyachi R; Takeuchi JS; Fujisawa T; Asano S; Komatsu M; Onami JI; Abe T; Arita M
    Genes Genet Syst; 2023 Nov; 98(5):221-237. PubMed ID: 37839865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CovRadar: continuously tracking and filtering SARS-CoV-2 mutations for genomic surveillance.
    Wittig A; Miranda F; Hölzer M; Altenburg T; Bartoszewicz JM; Beyvers S; Dieckmann MA; Genske U; Giese SH; Nowicka M; Richard H; Schiebenhoefer H; Schmachtenberg AJ; Sieben P; Tang M; Tembrockhaus J; Renard BY; Fuchs S
    Bioinformatics; 2022 Sep; 38(17):4223-4225. PubMed ID: 35799354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance.
    Zufan SE; Lau KA; Donald A; Hoang T; Foster CSP; Sikazwe C; Theis T; Rawlinson WD; Ballard SA; Stinear TP; Howden BP; Jennison AV; Seemann T
    Microb Genom; 2023 Nov; 9(11):. PubMed ID: 38019123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.